"Luminis Health Anne Arundel Medical Center(LHAAMC) is a regional health system headquartered in Annapolis, Maryland, and serves an area of more than one million people. Founded in 1902, LHAAMC includes a not-for-profit hospital, a medical group, imaging services, a substance use treatment center, and other health enterprises. In addition to a 57-acre Annapolis campus, AAMC has outpatient pavilions in Bowie, Kent Island, Pasadena, Odenton and Waugh Chapel. AAMC is nationally recognized for its joint replacement center, emergency heart attack response and cancer care. A leader in women's services, AAMC ranks second in Maryland for number of births annually and has a Level III neonatal intensive care unit."

During the past decade, Anne Arundel Health System Research Institute conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Anne Arundel Health System Research Institute" #1 sponsor was "Seres Therapeutics, Inc." with 2 trials, followed by "Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins" with 2 trials sponsored, "Smith & Nephew, Inc." with 2 trials sponsored, "American Regent, Inc." with 1 trials sponsored and "Bristol-Myers Squibb" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Anne Arundel Health System Research Institute" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Anne Arundel Health System Research Institute" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator, "Dignity Health" with 1 trials as a collaborator and "Duke Clinical Research Institute" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Anne Arundel Health System Research Institute" are "Atherosclerosis" (1 trials), "Carotid Stenosis" (1 trials), "Cerebral Infarction" (1 trials), "Clostridium Difficile" (1 trials) and "Clostridium Difficile Infection" (1 trials). Many other conditions were trialed in "Anne Arundel Health System Research Institute" in a lesser frequency.

Most popular intervention types in "Anne Arundel Health System Research Institute" are "Drug" (8 trials), "Device" (3 trials), "Dietary Supplement" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Apixaban" (1 trials), "Ascorbic Acid" (1 trials), "Carotid Artery Stenting (CAS)" (1 trials) and "Carotid Endarterectomy (CEA)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Anne Arundel Health System Research Institute" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Anne Arundel Health System Research Institute". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Anne Arundel Health System Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Anne Arundel Health System Research Institute, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".